Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST003101)

Reversed phase POSITIVE ION MODE (Analysis AN005074)

Metabolite	Structure	F1	F2	F3	F4
Dicoumaroyl Spermidine	ME808736	0.59	0.06	3.27	0.08
TG(12:0/14:1/18:1)	ME808795	0.18	0.41	0.18	3.23
LPC 16:0	ME808748	0.74	0.60	0.58	2.08
lysoPC(0:0/18:0)	ME808752	0.77	0.48	0.60	2.14
PE(16:0/0:0)	ME808768	0.52	0.39	0.36	2.73
PE(18:0/0:0)	ME808771	0.57	0.31	0.41	2.71
tyrosine	ME808809	0.50	0.56	0.45	2.49
LPC 18:1	ME808749	0.66	0.42	0.46	2.45
PE(18:1/0:0)	ME808772	0.63	0.36	0.42	2.59
TG(16:0/16:1/O-18:0)	ME808798	2.07	0.86	0.88	0.18
dotriacontenoic acid	ME808710	2.34	0.60	0.86	0.20
TG(16:1/18:2/O-18:0)	ME808801	2.31	0.74	0.86	0.09
dihydro prostaglandin F1alpha	ME808712	0.92	0.48	2.34	0.27
trihydroxyoctadecenoic acid	ME808702	1.04	0.48	2.35	0.14
sebacic acid	ME808789	0.75	1.24	1.88	0.13
PI(18:0/18:3)	ME808787	0.79	0.74	1.66	0.81
TG(16:0/18:1/18:3)	ME808800	0.90	0.73	1.82	0.55
desmesterol	ME808732	1.86	0.57	1.33	0.23
13,14-dihydro-19-hydroxyPGE1	ME808714	1.75	0.51	1.72	0.03
2,3-dinor-8-iso-PGF2a	ME808703	1.45	0.79	1.68	0.08
9-hydroxydec-2-enoic acid	ME808785	1.52	0.83	1.49	0.16
dodecadienoic acid	ME808739	1.54	0.72	1.46	0.28
PGG2	ME808782	1.42	1.16	1.28	0.14
methyl oleate	ME808783	1.15	1.12	1.51	0.22
octenoic acid	ME808705	1.12	1.07	1.61	0.20
hydroxybenzoic acid	ME808707	1.20	0.95	1.77	0.08
prostaglandin E-2	ME808788	1.25	1.03	1.64	0.07
hydroxyoxotetradecenoic acid	ME808700	1.20	0.73	1.83	0.24
13,14-dihydro-PGE1	ME808715	1.10	0.72	1.85	0.34
dehydro TXB2	ME808711	1.10	0.83	1.79	0.28
dodecadienoic acid_iso	ME808740	1.31	0.85	1.42	0.41
dihydro-15-keto prostaglandin D1	ME808713	1.16	0.88	1.62	0.34
PE(18:2/18:4)	ME808774	1.15	0.83	1.56	0.46
TG(24:0/24:1/18:1)	ME808807	1.11	0.84	1.61	0.45
DG(14:0/16:1/0:0)	ME808733	0.83	1.48	0.88	0.81
hydroxynonanal	ME808708	0.67	1.47	0.96	0.90
10-Hydroxy-2-Decenoic Acid	ME808784	0.65	1.49	0.97	0.89
cuminyl alcohol	ME808731	0.64	1.49	0.99	0.89
cinnamaldehyde	ME808726	0.67	1.86	0.90	0.57
trans-cinnamate	ME808808	0.59	2.13	0.82	0.46
dodecenoylcarnitine	ME808741	0.51	1.95	1.50	0.05
hydroxylauroylcarnitine	ME808704	0.74	1.65	1.53	0.08
orsellinic acid, ethyl ester	ME808756	0.86	1.54	1.34	0.26
TG(16:0/16:1/18:1)	ME808799	0.87	1.24	1.33	0.56
PE(16:0/16:1)	ME808769	1.11	1.42	0.93	0.54
PC(P-16:0/18:1-2OH)	ME808765	0.97	1.54	0.95	0.53
PE(20:1/20:0)	ME808776	1.02	1.55	0.93	0.50
phenylbutyric acid	ME808706	1.02	1.78	1.05	0.15
propylphenol	ME808709	1.00	1.71	1.04	0.25
hydroxydecenoic acid	ME808701	1.11	1.55	1.16	0.18
hydroxyprostaglandin E2	ME808716	1.22	1.49	1.21	0.08
cucurbic acid	ME808730	1.17	1.39	1.20	0.24
dihydrojasmone	ME808737	1.20	1.39	1.24	0.17
palmitoylcanitine	ME808759	1.31	1.44	0.42	0.83
ISTD_TG (15:0-18:1-d7-15:0)_791648	ME808747	1.39	0.93	0.90	0.79
TG(18:0/O-18:0/18:2)	ME808803	1.36	0.89	0.91	0.84
PC(16:1/16:1)	ME808763	1.24	1.13	0.98	0.65
b-sitosterol	ME808810	1.31	1.00	1.11	0.58
PE(P-16:0/16:0)	ME808779	1.36	0.97	1.12	0.56
dihydrotachysterol	ME808738	1.66	0.96	0.91	0.47
TG(18:1/22:1/O-18:0)	ME808804	1.60	0.77	1.05	0.58
TG(20:0/18:2/O-18:0)	ME808806	1.64	0.83	1.01	0.52
cer(d18:0/24:0)	ME808722	1.84	1.02	0.79	0.35
nordehydrolanosterol	ME808717	1.97	0.78	0.75	0.49
arachidyl carnitine	ME808718	0.66	0.98	0.63	1.72
TG(12:0/18:1/16:1)	ME808796	0.51	1.05	0.69	1.76
lysoPC(O-18:0/0:0)	ME808753	0.85	0.79	0.73	1.62
PC(16:1/0:0)	ME808762	0.97	0.74	0.69	1.61
(2-acetyloxy-3-hydroxypropyl) -octadecenoate	ME808699	0.74	1.00	0.76	1.50
noradrenaline	ME808755	0.66	1.07	0.83	1.44
SM(d14:0/20:0)	ME808790	0.67	1.07	0.78	1.48
DG(18:1/16:0/0:0)	ME808735	0.81	1.01	0.87	1.31
PC(14:0/14:0)	ME808760	0.88	0.89	0.87	1.36
ISTD_Lyso PC (18:1-d7)_791643	ME808743	0.97	1.08	0.92	1.04
ISTD_MG (18:1-d7)_791646	ME808744	0.99	1.08	0.94	0.99
SM(d16:1/22:0)	ME808792	0.90	1.15	0.94	1.02
sphingomyelin	ME808794	0.93	1.10	0.97	1.00
CL(i-13:0/a-25:0/18:2/i-18:0)	ME808728	0.95	0.99	1.07	1.00
ISTD_Cholesterol-d7_700041	ME808742	1.00	0.96	0.97	1.08
PE(22:2/22:0)	ME808777	1.01	0.99	1.00	1.00
TG(14:0/20:5(5Z,8Z,11Z,14Z,17Z)/18:4)	ME808797	0.97	0.99	1.00	1.04
PC(24:0/18:2)	ME808764	0.99	1.01	0.96	1.04
ISTD_PC (15:0-18:1-d7)_791637	ME808745	0.96	1.04	0.98	1.02
ISTD_SM (18:1-d9)_791649	ME808746	0.96	1.03	0.98	1.03
coenzyme Q9	ME808729	0.85	1.13	0.87	1.16
cer(d18:0/18:1)	ME808720	1.00	1.09	0.85	1.06
cer(d18:0/22:1)	ME808721	0.98	1.03	0.85	1.14
campesterol	ME808719	1.02	0.92	0.90	1.15
cer(d18:1/16:0)	ME808723	0.91	1.03	0.85	1.22
PE(P-16:0/20:0)	ME808780	0.94	1.03	0.93	1.11
CL(16:0/17:0/i-18:0/a-21:0)	ME808727	0.91	1.00	0.96	1.14
SM(d15:1(4E)/16:0)	ME808791	0.87	0.99	0.96	1.18
SM(d18:0/16:1)	ME808793	0.90	0.97	0.94	1.19
PE(16:0/18:1)	ME808770	1.02	1.18	1.00	0.80
PE(18:3/22:5)	ME808775	1.04	1.25	1.01	0.70
DG(18:0/18:2/0:0)	ME808734	1.18	0.89	0.99	0.95
LPC 18:1_iso	ME808750	1.10	0.99	0.99	0.91
PA(24:1/22:2)	ME808758	1.13	0.97	0.97	0.93
PE(O-16:0/18:1)	ME808778	1.03	1.04	1.05	0.89
LPE 18:1	ME808751	1.13	1.02	1.03	0.82
PE(18:1/18:0)	ME808773	1.11	0.98	1.13	0.77
PE(P-18:0/16:0)	ME808781	0.85	0.85	1.17	1.13
TG(18:0/18:2/20:4)	ME808802	0.92	0.75	1.17	1.16
cholesterol	ME808725	0.86	0.78	1.33	1.04
PA(22:6/22:2)	ME808757	0.87	0.84	1.36	0.93
PC(P-18:1/18:3-OH)	ME808767	0.87	0.85	1.35	0.92
ceramide 1	ME808724	1.17	0.68	1.41	0.75
TG(18:1/18:1/20:1)	ME808805	1.19	0.59	1.49	0.73
lysoPE(0:0/18:3)	ME808754	1.00	0.91	1.23	0.86
4-hydroxy-3-methoxyphenylethanol	ME808786	0.98	0.96	1.40	0.65
PC(16:0/18:3)	ME808761	1.05	0.87	1.36	0.72
PC(P-16:0/20:3-OH)	ME808766	1.05	0.92	1.28	0.76

Factors:

F1	Treatment:Banked
F2	Treatment:Early mated
F3	Treatment:Late mated
F4	Treatment:Virgin

Data matrix